Supernus Pharmaceuticals Inc Investor Day Transcript
Good morning, everyone. Thank you so much for joining us today. We appreciate you making the trip and spending a good portion of your day with us. I'm Jack Khattar, President and CEO of Supernus.
Before we get started, I just want to remind everyone that we will be making forward-looking statements about the business throughout the presentation as well as the Q&A session. So please refer to the SEC filings for all the risk factors associated with our business.
We have a fairly full agenda today. I'll start very briefly with brief introductions and a brief corporate overview, and then we're going to get into the substance of today's meeting, which is our pipeline, specifically, SPN-812, SPN-810, and SPN-604. And then we will have a general Q&A session at the end.
One little detail here. After SPN-812, we will also have a Q&A session. So I will really encourage everyone to please write down your questions and, if you don't mind, no interruptions of the presentation
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
